Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
N/A
Synonyms :
medical cannabis
Class :
Cannabinoid
Dosage Forms & StrengthsÂ
SpraysÂ
1 drop/doseÂ
Put 1 drop via sublingual route daily
Dosing modification
Renal Impairment
Drug modification not required
Hepatic Impairment
Drug modification not required
Not suggested Â
Refer to adult dosingÂ
cannabis: they may increase the CNS depressant effect of amino alcohol
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP3A4 inducers
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
Actions and SpectrumÂ
The primary active compounds in medical cannabis are cannabinoids, which interact with the body’s endocannabinoid system to produce various effects. Â
The two most well-known cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD). Type 1 (CB1) and type 2 (CB2) cannabinoid receptors may be directly or indirectly activated by THC and CBD when they interact with the endocannabinoid system.Â
Frequency not defined Â
Circulatory shockÂ
Deep vein thrombosisÂ
Dehydration, hot flashÂ
Acute myocardial infarctionÂ
Atrial fibrillationÂ
Cerebrovascular accidentÂ
Cellulitis, hyperhidrosisÂ
Pressure ulcer, pruritusÂ
Increased thirstÂ
Abdominal pain, constipationÂ
Increased appetite, nausea, oral mucosa ulcerÂ
Bladder dysfunctionÂ
Urinary tract infectionÂ
Decreased gastrointestinal motility, diarrheaÂ
Dysgeusia, dysphagia, gastroenteritisÂ
Anemia, leukopeniaÂ
Hepatic fibrosis, liver steatosisÂ
Hypersensitivity reactionÂ
Infection, sepsisÂ
LymphadenopathyÂ
Abnormal hepatic function tests Â
Abnormal dreams, aggressive behavior Â
Agitation, amnesiaÂ
Confusion, decreased mental acuity, delusionÂ
Lack of concentration, memory impairmentÂ
Anxiety, apathy, ataxia Â
Balance impairment, bipolar mood disorderÂ
Mood changesÂ
Mouth pain, myastheniaÂ
Cough, dyspneaÂ
Lower respiratory tract infection Â
Psychosis, schizophreniaÂ
Sedated state, seizure, speech disturbanceÂ
Asthenia, muscle spasm, muscle twitching Â
Nervousness, panic attackÂ
Paranoid ideation, ParesthesiaÂ
Myalgia, osteomyelitis, tremorÂ
Blurred vision, eye rednessÂ
TinnitusÂ
Acute pulmonary reaction (bronchodilation)Â
Drug tolerance, feverÂ
Black Box WarningÂ
None
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: some metabolites of drug may present in human milk Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
tetrahydrocannabinol (THC), the psychoactive component of cannabis, binds to cannabinoid receptor type 1 (CB1) receptors, particularly in the brain. By activating CB1 receptors, THC can produce various effects, including altered perception, mood changes, and euphoria.Â
PharmacodynamicsÂ
cannabidiol (CBD) has a low affinity for CB1 and CB2 receptors and does not produce psychoactive effects. CBD modulates the activity of CB1 receptors indirectly.Â
PharmacokineticsÂ
Absorption  Â
The absorption of medical cannabis depends on the route of administration. When cannabis is inhaled, the cannabinoids are rapidly absorbed through the lungs into the bloodstream. Â
DistributionÂ
medical cannabis is distributed throughout the body. Â
MetabolismÂ
medical cannabis is primarily metabolized in the liver. The main metabolic pathway for THC is through the liver enzyme cytochrome P450 (CYP450) system. Â
Elimination and excretionÂ
medical cannabis is excreted from the body primarily through urine and feces.
AdministrationÂ
medical cannabis can be administered through various routes like Inhalation in form of smoking; Oral; Sublingual in form of tincture and Topical in form of cream and lotion.
Patient information leafletÂ
Generic Name: medical cannabisÂ
Why do we use medical cannabis?Â
medical cannabis has shown promise in managing chronic pain conditions, such as neuropathic pain, arthritis and fibromyalgia.  Â
medical cannabis may help some individuals with insomnia or sleep disturbances.  Â
medical cannabis also used to reduce muscle spasms and spasticity.